Insight

Wafik El-Deiry: Toward a Biomedical Research Enterprise That Better Serves the United States

Wafik El-Deiry/brown.edu

Oct 4, 2024, 15:46

Wafik El-Deiry: Toward a Biomedical Research Enterprise That Better Serves the United States

Wafik El-Deiry shared a post on LinkedIn about a recent paper by Albert Reece et al. published in The New England Journal of Medicine homepage.

“Toward a Biomedical Research Enterprise That Better Serves the United States”

Authors: Albert Reece and Victor Dzau.

“Toward a Biomedical Research Enterprise That Better Serves the United States.

‘The decline of the U.S. biomedical research enterprise would have grave implications not only for scientific progress but also for the national health, economy, and overall prosperity.

‘We can easily imagine a future in which the United States no longer leads the pack in biomedical innovations and medical breakthroughs’.

‘We need a strategic vision and oversight body, as well as enhanced coordination at the national level’.

‘Because of silos and lack of coordination, redundant investigations occur in parallel, and important research questions are left unexplored’.

‘We need a workforce that is adequately compensated and able to focus on the issues that matter most’.

‘It is essential to act now, and act with purpose, to strengthen and reinvigorate the U.S. biomedical research enterprise.’ ”

Source: Wafik El-Deiry/LinkedIn

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.

He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.

AACI Albert Reece American Association for Cancer Research American Society of Clinical Oncology ASCO Association of American Cancer Institutes Brown University cancer National Academy of Medicine National Cancer Institute NCI OncoDaily Oncology The National Institutes of Health The New England Journal of Medicine homepage The Warren Alpert Medical School of Brown University Victor Dzau Wafik El-Deiry Warren Alpert Medical School

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage